Recognising alumni who are active in initiating and contributing to innovative or creative new ideas, solutions or business opportunities, that have the potential for growth.

Wang Wen – graduate of University of Aberdeen
Wang Wen is the CEO&CMO of IASO BIO, a global clinical-stage biotechnology company with 400+ employees, operating at China and US, dedicated to developing breakthrough cell therapies treating cancer and autoimmune diseases. With $178 Mn USD capital fund raised since 2017, he is leading the company going public and launching the Chinese 1st BCMA-CART therapy to the market treating cancer patients soon.